2022 Resolution on elevating pandemic prevention, preparedness and response to the highest level of political leadership

76th UNGA
2022-03-29

Res­o­lu­tion A/RES/76/257

Down­load

Source

Analysis of precedential value

This res­o­lu­tion was adopted by the UN Gen­eral Assem­bly (UNGA) with­out a gen­eral vote in March 2022. The UNGA is the pre­em­i­nent gov­ern­ing body of the UN sys­tem and con­sists of all 193 UN Mem­ber States.

Used as precedent

access to health products, publicly funded research

• “Calls upon Mem­ber States to pro­mote the trans­fer of tech­nol­ogy and know-how and encour­age research, inno­va­tion and com­mit­ments to vol­un­tary licens­ing, where pos­si­ble, in agree­ments where pub­lic fund­ing has been invested in research and devel­op­ment for pan­demic pre­ven­tion, pre­pared­ness and response, to strengthen local and regional capac­i­ties for the man­u­fac­tur­ing, reg­u­la­tion and pro­cure­ment of needed tools for equi­table and effec­tive access to vac­cines, ther­a­peu­tics, diag­nos­tics and essen­tial sup­plies, as well as for clin­i­cal tri­als, and to increase global sup­ply through facil­i­tat­ing trans­fer of tech­nol­ogy within the frame­work of rel­e­vant mul­ti­lat­eral agree­ments” (p. 6)

access to health products, local and regional manufacturing

• “Rec­og­niz­ing the need to sup­port devel­op­ing coun­tries in build­ing exper­tise and in devel­op­ing local and regional man­u­fac­tur­ing capac­i­ties for tools, includ­ing by build­ing on efforts under the COVID-19 Vac­cine Global Access (COVAX) Facil­ity, with a view to devel­op­ing improved global, regional and local man­u­fac­tur­ing, han­dling and dis­tri­bu­tion capac­i­ties while fur­ther enabling the increased use of health tech­nolo­gies and the dig­i­tal trans­for­ma­tion of health sys­tems” (p. 3)

access to health products, local and regional manufacturing, technology transfer

• “Empha­siz­ing the need to improve access to qual­ity, safe, effec­tive and afford­able vac­cines, ther­a­peu­tics, diag­nos­tics and other health tech­nolo­gies, inter alia, through build­ing capac­ity for local and regional pro­duc­tion, espe­cially in low- and mid­dle-income coun­tries, tech­nol­ogy trans­fer on mutu­ally agreed terms, coop­er­a­tion with, sup­port to and the devel­op­ment of vol­un­tary patent pools and other vol­un­tary ini­tia­tives, such as the World Health Orga­ni­za­tion COVID-19 Tech­nol­ogy Access Pool and the Med­i­cines Patent Pool, and pro­mot­ing generic com­pe­ti­tion in line with the World Health Orga­ni­za­tion road map for access to med­i­cines, vac­cines and other health prod­ucts, 2019–2023” (p. 4)

• “Calls upon Mem­ber States to pro­mote the trans­fer of tech­nol­ogy and know-how and encour­age research, inno­va­tion and com­mit­ments to vol­un­tary licens­ing, where pos­si­ble, in agree­ments where pub­lic fund­ing has been invested in research and devel­op­ment for pan­demic pre­ven­tion, pre­pared­ness and response, to strengthen local and regional capac­i­ties for the man­u­fac­tur­ing, reg­u­la­tion and pro­cure­ment of needed tools for equi­table and effec­tive access to vac­cines, ther­a­peu­tics, diag­nos­tics and essen­tial sup­plies, as well as for clin­i­cal tri­als, and to increase global sup­ply through facil­i­tat­ing trans­fer of tech­nol­ogy within the frame­work of rel­e­vant mul­ti­lat­eral agree­ments” (p. 6)